Prolonged preoperative treatment of acromegaly with Somatostatin analogs may improve surgical outcome in patients with invasive pituitary macroadenoma (Knosp grades 1â3): A retrospective cohort study conducted at a single center
BMC Endocrine Disorders Sep 11, 2017
Duan L, et al. - The purpose of this study was to evaluate preoperative somatostatin analogs (SSAs) treatment on the surgical outcome in patients with acromegaly. Clinicians exhibited evidence that the long-term preoperative SSAs treatment may enhance the surgical curative rate in acromegalic patients with invasive macroadenomas (Knosp grades 1Â3).
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
